Assesses mesenteric fibromatosis mimicry in patients with neuroendocrine tumors, suggesting need for careful diagnosis.
A 52-year-old man with a prior history of resected G2 pancreatic neuroendocrine tumor presented with a newly identified abdominal mass during 17-month follow-up. Contrast-enhanced MRI depicted a heterogeneously hyper-enhancing jejunal mesenteric lesion, highly suggestive of metastatic disease. ¹⁸F-AlF-NOTA-Octreotide PET/CT revealed mild tracer accumulation within the lesion, which was initially interpreted as NET metastasis. Surgical pathology ultimately confirmed mesenteric fibromatosis. This case emphasizes an important diagnostic trap, as benign fibromatosis can mimic NET metastasis on both anatomic and SSTR-targeted PET imaging, alerting clinicians to avoid misdiagnosis and unnecessary treatment.
No takes yet. Share an insight, caveat, or question.
Zhuang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: